Stock in Eli Lilly and Novo Nordisk outperformed last year, largely because of remarkable demand for new drugs that drive weight loss in patients afflicted with diabetes and obesity. Both stocks were ...
Tag: NVO
The Big Winners—and Losers —in the Inflation Bill
Senate Majority Leader Chuck Schumer (D-NY) helped shepherd the Inflation Reduction Act through the Senate after earlier bills died. Drew Angerer/Getty Images Text size The House won’t take up Democra...
NVO Stock: Obesity Sales Nearly Double, But That Wasn’t Enough For Investors
Danish drugmaker Novo Nordisk (NVO) missed second-quarter expectations Wednesday but raised its full-year outlook. NVO stock tumbled. X Sales climbed 25% to 41.27 million Danish Kroner — or about $5.6...